UK's biggest medical school looks for spin-off investors:
This article was originally published in Clinica
Spinning out commercial opportunities is the aim of most academic institutions around the world. However, some probably have a greater pool of technology from which to draw. One such organisation in the UK must be Imperial College in London, which is accelerating the rate at which it spins off companies, and has reached an average of one a month. As the largest medical faculty in the UK, with nearly 700 academic staff, the university is developing a number of commercial operations in the devices and diagnostics area.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.